Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Amarantus Bioscience Holdings, Inc. | Financial_Report.xls |
| EX-10.1 - EXHIBIT 10.1 - Amarantus Bioscience Holdings, Inc. | v386211_ex10-1.htm |
| EX-10.3 - EXHIBIT 10.3 - Amarantus Bioscience Holdings, Inc. | v386211_ex10-3.htm |
| EX-10.2 - EXHIBIT 10.2 - Amarantus Bioscience Holdings, Inc. | v386211_ex10-2.htm |
| EX-31.2 - EXHIBIT 31.2 - Amarantus Bioscience Holdings, Inc. | v386211_ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Amarantus Bioscience Holdings, Inc. | v386211_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - Amarantus Bioscience Holdings, Inc. | v386211_ex31-1.htm |
| 10-Q - 10-Q - Amarantus Bioscience Holdings, Inc. | v386211_10q.htm |
EXHIBIT 32.2
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Robert Farrell, the Chief Financial Officer of Amarantus BioScience Holdings, Inc. (the “Company”), hereby certify, that, to my knowledge:
1. The Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: August 14, 2014 | /s/ Robert Farrell |
| Robert Farrell | |
| Chief Financial Officer | |
| (Principal Financial Officer) |